Adjunctive rectal misoprostol versus oxytocin infusion for prevention of postpartum hemorrhage in women at risk: A randomized controlled trial

Journal of Obstetrics and Gynaecology Research

Volumn 38, Issue 11, 2012, Pages 1294-1301

  Badejoko, Olusegun O ^a   Ijarotimi, Adebimpe O ^a   Awowole, Ibraheem O ^a   Loto, Olabisi M ^a   Badejoko, Bolaji O ^a   Olaiya, Dare S ^b   Fatusi, Adesegun O ^a   Kuti, Oluwafemi ^a   Orji, Ernest O ^a   Ogunniyi, Solomon O ^a  

^a OBAFEMI AWOLOWO UNIVERSITY TEACHING HOSPITALS COMPLEX   (Nigeria)

^b FEDERAL MEDICAL CENTER   (Nigeria)

Author keywords

Misoprostol; Oxytocin; Postpartum hemorrhage; Prevention

Indexed keywords

MISOPROSTOL; OXYTOCIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FEVER; HEMATOCRIT; HUMAN; LABOR STAGE 3; MAJOR CLINICAL STUDY; NIGERIA; PILOT STUDY; POSTPARTUM HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL; SHIVERING; TREATMENT OUTCOME; UTERINE ATONY; VOMITING;

ADMINISTRATION, RECTAL; ADULT; DELIVERY, OBSTETRIC; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MISOPROSTOL; OXYTOCICS; OXYTOCIN; POSTPARTUM HEMORRHAGE; PREGNANCY; RISK FACTORS; TREATMENT OUTCOME;

EID: 84869196776     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2012.01869.x     Document Type: Article

References (26)

1. WHO/UNICEF/UNFPA/World Bank. Trends in Maternal Mortality 1990-2008. Estimates Developed by WHO, UNICEF, UNFPA and The World Bank. Geneva: World Health Organization, 2010.
2. Geller SE, Adams MG, Kelly PJ, Kodkany BS, Derman RJ. Postpartum hemorrhage in resource-poor settings. Int J Gynaecol Obstet 2006; 92: 202-211. (Pubitemid 43286980)
3. Ripley DL. Uterine emergencies: Atony, inversion, and rupture. Obstet Gynecol Clin North Am 1999; 26: 419-434. (Pubitemid 29399121)
4. Breathnach F, Geary M. Standard medical therapy. In: B-Lynch C, Keith LG, Lalonde AB, Karoshi M (eds). A Textbook of Postpartum Haemorrhage. Dumfriesshire, UK: Sapiens Publishing, 2006; 256-262.
5. The EUPHRATES group. European consensus on prevention and management of postpartum haemorrhage. European Union 5th framework, 2005.
6. Quiroga DR, Esparza AM, Batiza RV, Coronado LO, Herná ndez AS, Martí nez CJ. Vaginal misoprostol in the prevention of postpartum hemorrhage. Ginecol Obstet Mex 2002; 70: 572-575.
7. Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2007; (1): CD003249. DOI: 10.1002/14651858.CD003249. pub2. (Pubitemid 351820594)
8. Kirkwood BR, Sterne JAC (eds). Essential Medical Statistics, 2nd edn. Oxford, MA: Blackwell Science Ltd., 2003; 420.
9. Gupta B, Jain V, Aggarwal N. Rectal misoprostol versus oxytocin in the prevention of postpartum haemorrhage - A pilot study. Int J Gynaecol Obstet 2006; 94 (Suppl 2): S139- S140. (Pubitemid 44854918)
10. Hofmeyr GJ, Gü lmezoglu AM, Novikova N, Linder V, Ferreira S, Piaggio G. Misoprostol to prevent and treat postpartum haemorrhage: A systematic review and meta-analysis of maternal deaths and dose-related effects. Bull World Health Organ 2009; 87: 666-677.
11. Zuberi NF, Durocher J, Sikander R, Baber N, Blum J, Walraven G. Misoprostol in addition to routine treatment of postpartum hemorrhage: A hospital-based randomizedcontrolled trial in Karachi, Pakistan. BMC Pregnancy Childbirth 2008; 8: 40.
12. Alfirevic Z, Blum J, Walraven G, Weeks A, Winikoff B. Prevention of postpartum hemorrhage with misoprostol. Int J Gynaecol Obstet 2007; 99: S198-S201. (Pubitemid 350110441)
13. Gulmezoglu AM, Forna A, Villar J, Hofmeyr GJ. Prostaglandins for prevention of postpartum haemorrhage. Cochrane Database Syst Rev 2004; (1): CD000494.
14. Widmer M, Blum J, Hofmeyr GJ et al. Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: A multicentre, double-blind randomised trial. Lancet 2010; 375: 1808-1813.
15. Khan RU, El-Refaey H. Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labor. Obstet Gynecol 2003; 101: 968-974. (Pubitemid 36561263)
16. Caliş kan E, Meydanli MM, Dilbaz B et al. Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial. Am J Obstet Gynecol 2002; 187: 1038-1045. (Pubitemid 35178408)
17. Gharoro EP, Enabudoso EJ. Relationship between visually estimated blood loss at delivery and postpartum change in haematocrit. J Obstet Gynaecol 2009; 29: 517-520.
18. Razvi K, Chua S, Arulkumaran S, Ratnam SS. A comparison between visual estimation and laboratory determination of blood loss during the third stage of labour. Aust N Z J Obstet Gynaecol 1996; 36: 152-154. (Pubitemid 26160664)
19. Larsson C, Saltvedt S,Wiklund I, Pahlen S, Andolf E. Estimation of blood loss after cesarean section and vaginal delivery has low validity with a tendency to exaggeration. Acta Obstet Gynecol Scand 2006; 85: 1448-1452. (Pubitemid 44863762)
20. Hill JA, Fadel HE, Nelson MC, Nelson RM, Nelson GH. Blood loss at vaginal delivery. South Med J 1986; 79: 188-192.
21. Patel A, Goudar SS, Geller SE et al. Drape estimation vs. visual assessment for estimating postpartum haemorrhage. Int J Gynaecol Obstet 2006; 93: 220-224. (Pubitemid 44209053)
22. Blum J, Winikoff B, Raghavan S et al. Treatment of postpartum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: A double-blind, randomised, non-inferiority trial. Lancet 2010; 375: 217-223.
23. Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002; 17: 332-336. (Pubitemid 34168436)
24. Li C, Wang W, Summer SN et al. Molecular mechanisms of the antidiuretic effect of oxytocin. J Am Soc Nephrol 2008; 19: 225-232. (Pubitemid 351240644)
25. Gerstenfeld TS,Wing DA. Rectal misoprostol vs. intravenous oxytocin for the prevention of PPH after vaginal delivery. Am J Obstet Gynecol 2001; 185: 878-882. (Pubitemid 32980530)
26. Rajan PV, Wing DA. Postpartum hemorrhage: Evidencebased medical interventions for prevention and treatment. Clin Obstet Gynecol 2010; 53: 165-181.